You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it. In addition as per local health authority Regulations, some of our products are not approved for sales, marketing or distribution in all countries.
NO
YES
  • Slide Image

    Keep life flowing

    Kedrion’s plasma-derived therapies help people suffering from debilitating conditions like Hemophilia and Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.

  • Slide Image

    Keep life flowing

    Kedrion’s plasma-derived therapies help people suffering from debilitating conditions like Hemophilia and Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.

  • Slide Image

    Keep life flowing

    Kedrion’s plasma-derived therapies help people suffering from debilitating conditions like Hemophilia and Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.

  1. 1
  2. 2
  3. 3

News

CORPORATE

Kedrion Biopharma supports the launch of "Nature Italy"

The Company reaffirms and strengthens its commitment to research and innovation

read more 

CORPORATE

Kedrion alongside AICE on the 50th Ann. of the first AICE Triennial Conference

The company supports the reading of a scientific study on the role of Factor VIII in the protection of the joints

read more 

CORPORATE

Kedrion announces the appointment of a new CEO

Val Romberg from the USA, one of the most esteemed managers in the industry

read more 

2019
ANNUAL REPORT

Kedrion hilite image
Kedrion hilite image
Kedrion hilite image

OPEN INNOVATION